By Janet Choi, MD, Chief Medical Officer at Progyny
For most of us, the beginning of a new year is a time of both reflection and renewal. It’s a moment to take stock — as individuals, companies, and industries — of how far we’ve come, what we’ve learned and achieved, and to set new intentions for the year ahead.
In that spirit, I’d like to start this year with a call to action for all of us across the fertility and family-building ecosystem: to do better for those affected by infertility who want nothing more than the chance to build a healthy family.
Doing better means optimizing and personalizing the care journey for every individual and every family. Infertility is not a single pathway or a uniform experience. Each journey carries its own emotional, physical, and financial weight — and the care we deliver should reflect that reality. To truly personalize care, every clinical decision must be grounded in evidence, supported by data, and informed by outcomes we can trust.
But like all resolutions, following through requires more than good intentions. It requires rigorous data collection, transparent reporting, and shared benchmarks. It requires consistent clinical standards — and industry-wide accountability to those standards.
Last year, we published our annual, third-party-validated fertility outcomes report, continuing a decade-long commitment to openly sharing how our solutions perform for our members and employers. Once again, the data showed that Progyny significantly exceeds national benchmarks across key clinical measures of fertility success. But beyond the results themselves, there was a deeper message — one that feels especially salient as we consider where our industry needs to go next:
Because every outcome matters, how we measure and report those outcomes matters just as much.
For the 1 in 6 individuals affected by infertility, the path to parenthood can be emotionally draining, physically demanding, and financially burdensome. That journey requires an extraordinary level of trust — trust from members that their benefits partner is committed to the highest standards of care and outcomes, and trust from employers that their investment is delivering meaningful, cost-effective impact for their workforce.
Earning that trust depends on rigor and transparency. Yet today, standards for collecting and reporting IVF outcomes still vary widely. Some solutions rely on self-reported or selectively sampled data. Others use timelines or denominators that diverge from those established by CDC and SART, making apples-to-apples comparisons difficult and obscuring what results truly mean at scale.
Some variation in standards is expected in a field that has evolved as rapidly as fertility benefits in recent years. Nevertheless, we can — and must — do better.
If, as an industry, we truly want to personalize fertility care for all, we need shared expectations for outcomes reporting grounded in common standards:
- Count every member to eliminate selection bias. Outcomes reporting should be comprehensive and standardized — not based on self-reported samples. At Progyny, clinics are required to report outcomes for every treatment resulting in a pregnancy attempt. This approach enables complete, network-wide reporting across all members and clinics, representing more than 19,000 IVF transfers.
- Align with CDC and SART timelines. Outcomes can only be compared effectively when they follow consistent timelines for benchmarking. Progyny follows the standard 12-month reporting window used by both CDC and SART — a reasonable standard the industry should embrace.
- Be transparent about scale. When it comes to evaluating outcomes, scale matters. With any key metric, a 50% success rate for 19,000 IVF transfers is orders of magnitude more meaningful than a 50% success rate for 300 IVF transfers. Employers and members should be able to easily interpret and compare results in the context of scale and impact.
These standards are far from abstract; they directly affect people’s lives. When Progyny reports 41% fewer retrievals per live birth than the national average (as we reported in 2025), that means significantly less physical burden and emotional strain for members and families — and significantly lower costs for employers across their employee population.
At Progyny, our commitment to clinical excellence and transparency extends across the entire family-building and women’s health journey — from preconception through postpartum, return-to-work, parenting, midlife, and menopause. Personalization, accountability, and outcomes-driven care are not slogans; they are the foundation of how we design benefits, manage our network, and support our members. As a physician and clinical leader, I believe the trust of patients can never be assumed — it is earned through consistency, openness, and demonstrated results over time. Proud as I am of the progress we at Progyny have made to-date, I enter the new year with my Progyny colleagues both humbled and inspired to do better still — because individuals and families deserve nothing less.